Dr. Yi Lin, chair of the Cellular Therapeutics Cross-Disciplinary Group at the Mayo Clinic Cancer Center, explains how chimeric antigen receptor T-cell therapy (CAR T-cell therapy) works and where the research is headed next. This interview originally aired Sept. 22, 2018.
22 сен 2018
